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Introduction. Reduction of preterm birth is a major goal in obstetric care. We performed a systematic review of randomized
controlled trials and cohort studies on the effectiveness of the cervical pessary to prevent preterm birth. Methods. We searched
the electronic databases of MEDLINE and Embase from inception until April 2012 to identify studies investigating treatment with
a cervical pessary to prevent preterm birth. We constructed two-by-two tables for delivery before 28, 34, and 37 weeks of gestation
and calculated relative risks (RRs) with 95% confidence intervals. Results. The search revealed 103 potentially eligible abstracts
of which six cohort studies and four randomized controlled trials (RCTs) investigated the effectiveness of the pessary. One RCT
(𝑛 = 380) demonstrated a lower delivery rate prior to 34 weeks (RR 0.24; 95%CI 0.13–0.43) in the pessary group, while another RCT
(𝑛 = 108) showed no positive effect of pessary for delivery before 34weeks (RR 1.73; 95%CI 0.43–6.88). Two older quasi randomized
studies and cohort studies indicated potential effect of the pessary. Conclusions. Available randomized and nonrandomized studies
indicate potential effectiveness of a cervical pessary in the prevention of preterm birth. More randomized clinical trials are needed
before this device can be used in clinical practice.
1. Introduction
Preterm birth (PTB) is the most common cause of perinatal
morbidity and mortality; therefore, preventing PTB is one
of the most important targets in the current obstetric care.
Mechanical prevention of preterm birth was proposed six
decades ago by the use of the Shirodkar and McDonald
cerclage [1, 2]. The effectiveness of these interventions has
been assessed in two Cochrane reviews.
Thefirst Cochrane review amongwomenwith risk factors
for preterm delivery or a history of miscarriages pooled the
result of four studies (𝑛 = 1035) and showed no significant
reduction in PTB <37 weeks when using a cerclage (RR 0.88,
95% CI 0.76–1.03). Three studies (𝑛 = 388) reporting on
delivery before 32 weeks of gestation were pooled and none
showed a reduction in preterm birth <32 weeks due to the
cerclage (RR 1.29, 95% CI 0.67–2.49) [3].
The second Cochrane review on cervical cerclage among
women with a singleton pregnancy at high risk of PTB based
on their history (e.g., previous PTB, cervical surgery, short
CL on ultrasound, or detected cervical changes) showed a
significant reduction in PTB before 37 weeks of gestation
(𝑛 = 2898, RR 0.80, 95% CI 0.69–0.95) and before 34 weeks
of gestation (𝑛 = 2392, RR 0.79, 95% CI 0.68–0.93) [4]. In
both reviews, cervical cerclage was associated with a higher
rate of maternal side effects (pyrexia, vaginal discharge and
bleeding) and larger number of caesarean sections.
Meta-analysis assessing of the effectiveness of a cervical
cerclage in women with a multiple pregnancy showed an
increased risk of PTB before 35 weeks (RR 2.2, 95% CI 1.2–
4.0) and a trend towards higher perinatal mortality (RR 2.7,
CI 95% 0.83–8.5) [5].
The data discussed previously does not allow a firm
conclusion on the use of cerclage to prevent preterm birth.
While it should not be used in twins, at present there remains
controversy on its effectiveness in singleton pregnancies.
An alternative for a cerclage is a cervical pessary. Vaginal
pessaries have been used to prevent preterm birth since 1959
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[6]. During the pregnancy the cervix normally stays tightly
closedwith a cervicalmucus plug (CMP) sealing the opening.
It is hypothesized that impairment of the CMP, for example,
by cervical effacement, can lead to an ascending infection and
pretermdelivery; nevertheless, this needs further clarification
[7]. The vaginal pessary encompasses the cervix and com-
presses the cervical canal, and somay prevent deterioration of
the CMP.The pessary alternates the inclination of the cervical
canal and corrects the incompetent cervix pointing forward
in the axis of the vagina. It relieves direct pressure on the
internal cervical os by distributing the weight of the pregnant
uterus onto the vaginal floor, retrosymphyseal osteomuscular
structures, and Douglas cavity and somay prevent premature
dilatation of the cervix and premature rupture of the mem-
branes. Furthermore, it blocks the fetal head fromdescending
and pressing on the internal ostium [6, 8].
The cervical pessary is a relatively noninvasive, not oper-
ator-dependent intervention, which can be easily placed or
removed in an outpatient clinic and does not require anes-
thesia. With speculum examination, the cervix is identified
to determine an appropriate pessary size. The silicon Arabin
pessary is themost popular and has different sizes of diameter
and height. It is flexible and fits high around the cervix, so
that the smaller inner diameter encompasses the cervix. After
placement the patient is briefly observed to ensure there is no
discomfort, vaginal blood loss, or uterine activity.
The aim of this study is to systematically review the liter-
ature about the use of the cervical pessary to prevent preterm
birth before 28, 34, and 37 weeks of gestation.
2. Methods
2.1. Search Strategy. We searched the electronic databases of
MEDLINE (US National Library of Medicine, Betheshda,
MD, USA) and Embase (Elsevier, Amsterdam, The Nether-
lands) from inception to November 2012. The search was
assisted by a clinical librarian and included “Obstetric Labor”
AND “Premature” OR “Premature” OR “Preterm” AND
“Birth” OR “Deliver” OR “Labor” OR “Labour” OR “Uterine
cervical incompetence” OR “Cervix” OR “Cervical” AND
“Incompetence” OR “Incompetent” AND “Pessaries” OR
“Pessaries” OR “Pessary” MeSH or key terms. We checked
reference lists to identify articles not found by electronic
searches. We identified randomized controlled trials as well
as cohort studies on the effectiveness of a cervical pessary to
prevent preterm birth.
2.2. Study Selection. Identified articles were screened by two
independent reviewers (S. Liem and M. van Pampus) on title
and abstract to determine their appropriateness for inclusion.
The studies should have preterm birth as their primary or sec-
ondary outcome and report on the use of a cervical pessary.
If studies could not be excluded based on their abstract or
title, a full manuscript was obtained. We did not apply any
language restrictions. If an article was written in a language
other than Dutch or English, it was translated by a colleague
with expertise in this language. If information available from
the publications was not sufficient, the primary authors were
contacted. If any disagreements about study inclusion arose,
the two reviewers had a discussion. If consensus could not
be reached a third reviewer (B. Mol) determined whether the
study should be included.
2.3. Data Extraction and Synthesis. The two reviewers ab-
stracted the data separately. The following data and infor-
mation were extracted from each eligible study: first author,
year of publication, country, number of women, inclusion
and exclusion criteria, type of pessary, definition of preterm
birth, population demographics, neonatal outcome, pessary
removal, and side effects.
Methodological quality of included studies was deter-
mined by using the Delphi list for quality assessment of
randomized clinical trials by both reviewers independently
[9]. We evaluated the following items: treatment allocation,
method of randomization, group’s similarity at baseline, spec-
ified eligibility criteria, blinding of outcome assessor, blinding
of care provider, blinding of patient, point estimates and
measures of variability presented for the primary outcome
measures, and intention-to-treat analysis. For the included
studies, relative risks (RRs) and 95% confidence intervals
(CIs) for delivery before 28, 34 and, 37weeks of gestationwere
calculated from two-by-two tables.
3. Results
The Ovid MEDLINE search (inception to November 2012)
retrieved 75 records, whereas the Embase search revealed
another 50 records. In total, 104 papers were excluded based
on titles and abstracts or due to duplicates. Furthermore,
we excluded 11 studies for other reasons: guidelines (𝑛 =
1), reviews (𝑛 = 4), study protocol (𝑛 = 1), case reports
(𝑛 = 4), and study not available (𝑛 = 1), leaving 10 studies
for inclusion in this systematic review (Figure 1). Study
characteristics and results for cohort studies and randomized
controlled trials are summarized (Tables 1 and 2).
4. History
The first publications on the cervical pessary were small case
studies in which well-defined in- and exclusion criteria as
well as specified outcomes were lacking. In 1959, Cross was
the first to publish on the use of the cervical pessary in 13
women with a history of incompetent cervix. Eight (62%)
pregnancies went to full-term, one ended in a miscarriage, in
one pregnancy an additional cervical cerclagewas placed, and
three pregnancies were on-going at the time of publication
[10]. In 1961, Vitsky used a Smith pessary to prevent preterm
birth in three patients with an incompetent cervix or a history
of late miscarriage. Before treatment, these women together
had six failed pregnancies prior to 20 weeks and four fetal
losses between 24 and 28 weeks. In these three women,
five pregnancies were treated with a pessary, of which four
continued to full-term pregnancies [6].
In 1966, Oster and Javert published on the Hodge pessary
as an alternative for the possibly hazardous cervical cerclage.
They performed a study on women with an obstetric history
of high fetal mortality rate because of recurrent miscarriage
and preterm birth due to the incompetent cervical os. Before
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Citations excluded after screening titles
Reason for exclusion
Citations excluded after removing
Total studies identified from initial search (𝑛 = 125)
duplicates (𝑛 = 8)
and/or abstracts (𝑛 = 96)
Potential studies reviewed for detailed information (𝑛 = 21)
Studies included in the review (𝑛 = 10)
Excluded studies (𝑛 = 11)
- Guideline (𝑛 = 1)
- Study protocol (𝑛 = 1)
- Study not available (𝑛 = 1)
- Case studies (𝑛 = 4)
- Review (𝑛 = 4)
- RCT (𝑛 = 4)
- Cohort studies (𝑛 = 6)
- Embase (𝑛 = 50)
- MEDLINE (𝑛 = 75)
Figure 1: Flowchart.
the treatment of these 29 women (94 pregnancies), 94 infants
were born of whom 16 (17%) were born after 37 weeks of
gestation. In the 35 subsequent pregnancies, these women
were treated with a pessary and had 23 (66%) term births [8].
4.1. Cohort Studies. Quaas et al. treated 59 women for
prophylactic and 44 women for therapeutic indications with
an Arabin pessary. Reasons for prophylactic treatment were
a history of miscarriages or preterm birth and multiple
pregnancies. Women with a cervical conization, cervical tear,
or cervical ripening (bishop score > 6) were treated with a
pessary for therapeutic indications. Another fivewomenwere
treated with the pessary instead of an emergency cerclage
because of cervical dilation or prolapsed membranes. Four
(80%) of these women had an uncomplicated prolongation
of their pregnancy. In total, 98 (92%) of the patients treated
with the pessary delivered after 36 weeks of gestation [11].
Arabin et al. treated 11 womenwith a short cervical length
(<15mm), four womenwith a singleton pregnancy, and seven
women with a twin pregnancy, with a cervical pessary. The
mean gestational age forwomenwith a singletonwas 35+3 and
for women with a twin pregnancy 35 weeks. No one delivered
before 32 weeks of gestation. Furthermore, a retrospective
matched pair analysis was performed. Patients treated with a
pessary were matched to patients without treatment, where
cervical length did not differ more than 2mm at the same
gestational age. The mean gestation age was 38 weeks for
singletons in the treatment group (𝑛 = 12) and 33+4 in the
control group (𝑛 = 12) (𝑃 = 0.02). For twin pregnancies, the
mean gestational age was 35+6 in the pessary group (𝑛 = 23)
and 33+2 in the control group (𝑛 = 23) (𝑃 = 0.02). In single-
ton pregnancies, no one delivered before 36 weeks in the
treatment group compared to six cases in the control group
(𝑃 < 0.001). This effect was not significantly shown for twin
pregnancies (8 women (35%) in the pessary group versus 12
(52%) in the control group) [12].
Antczak-Judycka et al. studied the effectiveness of the
pessary (𝑁 = 35) versus the McDonald cerclage (𝑁 = 22)
in womenwith clinically and ultrasonographically confirmed
shortening of the cervix between 22–27 weeks of gestation.
There was no difference in prolongation gestational age (13.4
weeks versus 12.1 weeks for cerclage and pessary, resp. (𝑃 =
0.06)). They showed that the choice of the method does not
affect the mode of delivery as well as neonatal outcome [13].
In a prospective cohort study by Acharya et al., 32 women
with a cervical length <25mm before 30 weeks of gestation
were treated with an Arabin pessary. There were 21 women
with a singleton, nine with a twin, and two with a triplet
pregnancy. Three women were excluded from analysis: two
required early delivery due to severe intrauterine growth
restriction and one due to HELLP syndrome. Delivery before
28 weeks occurred in six (20.7%) women and before 34 weeks
in 13 (45%) women. The mean gestational age at delivery
was 34weeks. Neonatal outcome demonstrated the following:
mean birthweightwas 2,255 g,meanApgar score at 5minwas
8 and 4 (13,8%) perinatal deaths [14].
Women with a singleton pregnancy and a cervical length
between 15–30mm before 28 weeks of gestation were treated
with a pessary in a study by Sieroszewski and coworkers. Nine
(16.7%) women delivered before 37 weeks of gestation. The
mean gestational age at delivery was 35.3 ± 4.4 weeks. Two
(3.9%) children were admitted to the neonatal intensive care
unit (NICU), there were no neonatal deaths [15].
In 2010, Kimber-Trojnar et al. used a cervical pessary in 56
women with increased risk of preterm birth (such as history
of miscarriages, prior PTB <34 weeks, cervical suture in
previous pregnancy, history of cervical laceration or cervical
coniztation, and twin pregnancies). The results demonstrate
two (3.6%) deliveries before 34 weeks and eight (15%) before
37 weeks of gestation. The mean gestational age at delivery
was 38.3 (30.4–41). All born infants, 58 (100%), were alive
[16].
4.2. Randomized Controlled Trials. Among the four random-
ized studies, two were truly randomized while two others
used quasi randomization. In 1986, Forster et al. compared
112 patients with a singleton pregnancy treated with cervical
cerclage to 130 patients with a Stu¨tz pessary. There was
a third group of bedrest, but all these patients needed
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additional therapy, so data on this group was not reported by
Forster et al. Entry criteria were not well described, and the
authors used quasi randomization based on the initial of the
woman’s surname. Delivery before 28 weeks (0.9% cerclage
versus 0% pessary group), between 28 and 30 weeks (2.7%
versus 2.3%), between 31 and 33 weeks (5.6% versus 3.1%),
between 34 and 36 weeks (14.3% versus 14.6%), and after
37 weeks (76.8% versus 80%) did not differ between both
groups. Furthermore, there was no significant different in
gestational age (37.57 weeks versus 38.15 weeks for cerclage
versus pessary), perinatal mortality (2 (1.7%) versus 0 (0%)),
birthweigth (3062.7 g versus 3097.9 g), or 5 minutes Apgar
scores (8.62 versus 8.67) [17].
In 1991, Gmoser et al. performed a randomized prospec-
tive study in which women were assigned to a pessary group
(𝑛 = 169) and a control group (𝑛 = 131). The randomiza-
tion method and in- and exclusion criteria were not well
described. Women in this study were at high risk for preterm
birth due to cervical dilatation after contractions (𝑁 = 109),
cervical widening without contractions (𝑁 = 95), a history
of cervical incompetence (𝑁 = 18), twin pregnancy (𝑁 =
52), and a preterm birth despite a prophylactic cerclage in a
previous pregnancy (𝑁 = 26). The median gestational age at
delivery in the pessary group was 39 weeks versus 36 weeks
in the control group. Birthweight was 2950 g in the pessary
group and 2400 g in the control group [18].
The PECEP study was a multicenter RCT that random-
ized 385 women with a singleton pregnancy and a short CL
(<25mm) at routine second trimester ultrasonography (18–
22 weeks) for a pessary (𝑁 = 192) or expectant management
(𝑁 = 193). Five women were lost to followup. Women with a
major fetal abnormality, painful regular uterine contractions,
active vaginal bleeding, ruptured membranes, placenta prae-
via, and a history of cone biopsy or cervical cerclage in situ
were not included. The primary outcome, that is, delivery
before 34 weeks of gestation, occurred less in the pessary
group compared to the expectant management group (6%
versus 27%, RR 0.24 CI 95% 0.13–0.43), as did delivery before
37 weeks of gestation (41 (22%) versus 113 (59%) women in
the pessary and control group (RR 0.36; CI 95% 0.27–0.49)),
and delivery before 28 weeks of gestation (4 (2%) women in
the pessary versus 16 (8%) in the control group (RR 0.25;
CI 95% 0.09–0.73)). The mean gestation age at delivery was
37.7 weeks in the pessary group versus 34.9 in the expectant
management group (𝑃 < 0.0001) [19].
Hui et al. randomized 108 women with a singleton
pregnancy and a cervical length <25mm at routine second
trimester ultrasonography (20–24 weeks) to the pessary (𝑁 =
53) and the control (𝑁 = 55) group. Women with a major
fetal abnormality, history of cervical incompetence, surgical
cerclage in current or previous pregnancy, multiple gestation,
presence of cervical dilatation, painful uterine contractions,
or ruptured membranes were not included. The investigators
did an attempt to blind the patients by performing a vaginal
examination and simulate the insertion of a pessary in all
women. The primary outcome, that is, delivery before 34
weeks of gestation, occurred in five (9%) women in the
pessary group versus three (6%) in the control group (RR
1.7; 95% CI 0.43–6.9). Delivery before 37 weeks of gestation
occurred in eight (15%) women in the pessary group and ten
(18%) women in the control group (RR 0.83; CI 95% 0.35–
1.94) and delivery before 28 weeks of gestation in two (4%)
women in the pessary versus three (6%)women in the control
group (RR 0.69; CI 95% 0.12–3.97).Themean gestation age at
delivery was 38.1 weeks in the pessary group versus 37.8 weeks
in the expectant management group [20].
5. Discussion
This systematic review included six cohort studies and four
randomized controlled trials studying the effectiveness of a
cervical pessary to prevent preterm birth. The cohort studies
indicated potential effectiveness of the pessary, while the
randomized studies showed conflicting results.
The PECEP trial demonstrated a significant reduction of
preterm delivery of gestation by treatment with a pessary, but
this effect was not confirmed by Hui et al. [19, 20]. A possible
explanation for the difference between these studies might
be the fact that the preterm delivery rate was much higher
in the control group from the PECEP trial (8% before 28
weeks, 27% before 34 weeks and 59% before 37 weeks) than
in the study by Hui et al. (6% before 28 weeks, 6% before 34
weeks, and 18% before 37 weeks). A study by Blencowe et al.
for worldwide estimates of preterm birth rates demonstrated
similar results for China and Spain (7.1 versus 7.4, resp.) [21].
Althoughwomenwith a short cervical length have a 3–6 folds
increased risk, this does not clarify the variance between both
studies [22, 23].
Differences in the baseline preterm birth rate are partially
explained by differences in baseline characteristics between
the two studies. On baseline, the PECEP study population
had a higher BMI (24.7 versus 21.8), and had a higher pre-
valence of smoking (19.5% versus 3.7%), had more women
with a history of preterm delivery (11% versus 8.3%), and the
population was mostly white or Latin American. Neverthe-
less, further evaluation is required to clarify whether the
PECEP study recruited women with additional risk factors
that could explain the differences between preterm delivery
rates.
Furthermore, both studies demonstrate differences in
their sample size calculation. The PECEP needed to recruit
380 women in five hospitals to show a reduction of PTB
<34 weeks from 28% to 14% [19]. Hui et al. recruited in one
centrewith a target sample size of 1120women to demonstrate
a reduction of PTB before 34 week from 8% to 4% [20].
Enrolment was slow with 100 women recruited in 29 months.
To determine whether to reevaluate the sample size or extend
the study to other centers, the authors decided to analyse their
data for the first 108 women.
The rates of PTB <34 weeks were lower than expected in
the control group (actual 5.5% versus expected 8%). Around
the same time, the results of the PECEP trial were published
demonstrating different outcomes. Hui et al. decided to stop
their study and publish their results. Since this study did not
achieve their target sample size and, therefore, most likely is
underpowered, it is difficult to formulate recommendations
for clinical practise based on these results.
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Although, due to the nature of the intervention it was
impossible to blind randomization. Hui et al. did an attempt
to blind the patient to the allocation. Patients in the control
group received a vaginal digital examination simulating the
insertion of a pessary. Treatment allocation was only revealed
to the obstetrician in charge after the patient was consented.
The use of a pessary might have affected medical decision
making, but we believe that the fact that patients were blinded
does not explain the different outcomes between both studies.
The safety of the treatment with a pessary is investigated
in several studies. Overall, the insertion and removal of
the pessary is simple and well tolerated by women. Arabin
showed, in a patient prevalence questionnaire evaluation, that
75% of the treatment group would use the pessary again and
would even recommend it to others.They reported that there
might be some increase of vaginal discharge [12]. According
to the maternal satisfaction questionnaire used in the PECEP
trial, 95% of women would recommend the vaginal pessary
to other people [19]. A study in 200 pregnant women with
a pessary was compared to women with normal pregnancies
concerning microbiological findings and puerperal morbid-
ity.There was no higher infection morbidity compared to the
control group [24].
Despite our extensive search, we could only identify
four randomized controlled trials, of which two fulfilled the
current standards. It is remarkable that an intervention used
since 1959 has been evaluated in several prospective cohort
studies or non-randomized comparative studies and only in
two well-designed RCTs.
Recently, Chang et al. reported an analysis of trends and
potential reductions with interventions in countries with a
very high human development index. They formulated a
target of a 5% relative reduction of preterm birth rate from
9.59% to 9.07% of live births, using smoking cessation (0.01
rate reduction), decreasing multiple embryo transfers during
assisted reproductive technologies (0.06), cervical cerclage
(0.15), progesterone supplementation (0.01), and reduction
of nonmedically indicated labour induction or caesarean
delivery (0.29) [25].The use of a pessary was not used in their
recommendations, obviously due to the limited evidence on
the subject.
The studies mainly included women with a singleton pre-
gnancy at high risk for a preterm delivery. Women with a
multiple pregnancy are at increased risk for preterm delivery
too. In The Netherlands, approximately 50% of women with
a multiple pregnancy deliver before 37 weeks of gestation, of
whom 9% even before 32 weeks [26]. In the United States,
these rates are 60% and 12%, respectively. In comparison, in
women with singleton pregnancy 6%–10% deliver before 37
weeks and 1% before 32 weeks. Future research should also
focus on the use of a cervical pessary in multiple pregnancies
[27].
In conclusion, the cervical pessary seems an affordable,
safe, and reliable alternative for prevention of PTB in a
population of appropriately selected at-risk pregnant women
who have been screened for cervical length assessment at the
midtrimester scan. In view of the differences in outcomes
between Hui et al. and the PECEP trial, further research is
urgently needed to confirm the efficacy of cerclage pessary in
prevention of preterm birth.
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